Oncology Views & Analysis

Views & Analysis

Patient research is critical to brand success, particularly ...

We see it time and time again in the treatment of cancer – pharma companies focusing all their effort on oncologists.

Views & Analysis

Macrophage Pharma goes for gold with new funding round

Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases.

Views & Analysis

Helsinn’s Riccardo Braglia on the patient perspective in can...

Swiss cancer care company Helsinn has become unique in the industry by remaining a family business over three generations.

Views & Analysis

Antibody-drug conjugates on the march

One of AstraZeneca’s most decisive moves last year came in March, when it signed a multi-billion dollar deal with Japan’s Daiichi Sankyo, focused on just one breast cancer drug.

Views & Analysis